Comparative Effectiveness of Somatostatin and Octreotide for Preventing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography: A Retrospective Study
High-dose somatostatin (at least 6 mg) or octreotide (at least 0.5 mg) within 24 h after ERCP are suggested for preventing PEP in patients at average risk.
Authors
- Tielong Wu (ORCID: https://orcid.org/0000-0002-0824-4750)
- Zijun Fan
- Yuzheng Xue
- Tianhao Liu
- Yingyue Sheng
- Wenhui Duan
- Yilin Ren
Institutions
- Jiangnan University (CN)
- Wuxi Fourth People's Hospital (CN)
Publication Details
- Journal
- ANZ Journal of Surgery
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1111/ans.70471
- Primary Topic
- Gallbladder and Bile Duct Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China